Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial - Harrison, SA; Bashir, MR; Guy, CD (Lancet, 2019)
et al.